IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,721,600 | -64.9% | 60,000 | -68.3% | 0.04% | -69.6% |
Q2 2023 | $7,754,670 | +26.7% | 189,000 | +10.4% | 0.14% | +16.9% |
Q1 2023 | $6,118,688 | +89.5% | 171,200 | +100.2% | 0.12% | +131.4% |
Q4 2022 | $3,229,335 | -33.6% | 85,500 | -22.3% | 0.05% | -23.9% |
Q3 2022 | $4,866,000 | -34.3% | 110,000 | -45.0% | 0.07% | -34.3% |
Q2 2022 | $7,404,000 | +91.6% | 200,000 | +57.5% | 0.10% | +131.8% |
Q4 2021 | $3,864,000 | -51.2% | 127,000 | -46.2% | 0.04% | -51.1% |
Q3 2021 | $7,916,000 | -46.3% | 235,993 | -36.1% | 0.09% | -53.1% |
Q2 2021 | $14,732,000 | +446.0% | 369,307 | +515.5% | 0.19% | +231.0% |
Q1 2021 | $2,698,000 | -82.1% | 60,000 | -77.5% | 0.06% | -83.1% |
Q4 2020 | $15,108,000 | +39.6% | 267,227 | +17.2% | 0.34% | +36.0% |
Q3 2020 | $10,819,000 | -29.0% | 228,000 | -11.7% | 0.25% | -50.1% |
Q2 2020 | $15,228,000 | +162.4% | 258,276 | +186.0% | 0.51% | +73.6% |
Q2 2019 | $5,804,000 | -31.9% | 90,300 | -14.0% | 0.29% | -37.9% |
Q1 2019 | $8,523,000 | – | 105,000 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |